Combine and conquer: handling biotech combination inventions in the wake of KSR.
To what extent will KSR limit combination inventions in biotech?
Wong
Ha Kung
HK
Fitzpatrick, Cella, Harper & Scinto, New York, New York, USA. hwong@fchs.com
Lau
Dana
D
D001709:Biotechnology; D010330:Patents as Topic; D035521:Supreme Court Decisions; D014481:United States